Efficacy of Dupilumab on Different Phenotypes of Atopic Dermatitis: One-Year Experience of 221 Patients.

Simona TavecchioLuisa AngileriFrancesco Pozzo GiuffridaFrancesca GerminiasiAngelo Valerio MarzanoSilvia Ferrucci

Published in: Journal of clinical medicine (2020)

The present study confirmed the efficacy and safety of dupilumab in the treatment of severe AD. Its strength was in the stratification of AD patients in six different phenotypes based on their clinical presentation, all of whom markedly improved in terms of both clinically evident and reported symptoms, as well as their quality of life.

Keyphrases

atopic dermatitis
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
patient reported
combination therapy